Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Amphastar Pharmaceuticals Q3 Adj. EPS $0.15 Beats $0.14 Estimate, Net Sales $83.40M Miss $91.26M Estimate


Benzinga | Nov 6, 2020 06:53AM EST

Amphastar Pharmaceuticals Q3 Adj. EPS $0.15 Beats $0.14 Estimate, Net Sales $83.40M Miss $91.26M Estimate

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.14 by 7.14 percent. This is a 50 percent increase over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $83.40 million which missed the analyst consensus estimate of $91.26 million by 8.61 percent. This is a 4.07 percent increase over sales of $80.14 million the same period last year.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC